Jessica González

ORCID: 0000-0002-6847-5315
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Long-Term Effects of COVID-19
  • Respiratory Support and Mechanisms
  • COVID-19 Clinical Research Studies
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Intensive Care Unit Cognitive Disorders
  • Lung Cancer Diagnosis and Treatment
  • MicroRNA in disease regulation
  • Extracellular vesicles in disease
  • Sepsis Diagnosis and Treatment
  • Thermal Regulation in Medicine
  • Lung Cancer Treatments and Mutations
  • COVID-19 and Mental Health
  • Pulmonary Hypertension Research and Treatments
  • Obstructive Sleep Apnea Research
  • Nutritional Studies and Diet
  • Asthma and respiratory diseases
  • Cardiovascular Disease and Adiposity
  • Circadian rhythm and melatonin
  • Obesity, Physical Activity, Diet
  • SARS-CoV-2 and COVID-19 Research
  • Cardiovascular Health and Disease Prevention
  • Cystic Fibrosis Research Advances
  • Respiratory viral infections research
  • Bone health and osteoporosis research
  • Diabetes, Cardiovascular Risks, and Lipoproteins

Mayo Clinic in Florida
2024-2025

Mayo Clinic
2024-2025

Biomedical Research Institute of Lleida
2019-2025

Instituto de Salud Carlos III
2019-2025

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
2019-2025

Hospital Universitari Arnau de Vilanova
2019-2025

Centro de Investigación Biomédica en Red
2022-2024

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
2023-2024

The University of Texas Health Science Center at Houston
2024

Mayo Clinic in Arizona
2024

To evaluate the sleep and circadian rest-activity pattern of critical COVID-19 survivors 3 months after hospital discharge.Observational, prospective study.Single-center study.One hundred seventy-two consecutive admitted to ICU with acute respiratory distress syndrome.Seven days actigraphy for assessment; validated questionnaires; tests at 3-month follow-up.The cohort included 172 patients, mostly males (67.4%) a median (25th-75th percentile) age 61.0 years (52.8-67.0 yr). The number was...

10.1097/ccm.0000000000005476 article EN Critical Care Medicine 2022-02-18

OBJECTIVES: To investigate the sleep and circadian health of critical survivors 12 months after hospital discharge to evaluate a possible effect severity disease within this context. DESIGN: Observational, prospective study. SETTING: Single-center PATIENTS: Two hundred sixty patients admitted ICU due severe acute respiratory syndrome coronavirus 2 infection. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The cohort was composed 260 (69.2% males), with median (quartile 1–quartile 3) age...

10.1097/ccm.0000000000006298 article EN cc-by-nc-nd Critical Care Medicine 2024-04-10

The primary aim of our study was to investigate the association between intubation timing and hospital mortality in critically ill patients with coronavirus disease 2019 (COVID-19)-associated respiratory failure. We also analysed both impact such throughout first four pandemic waves influence prior noninvasive support on outcomes.This is a secondary analysis multicentre, observational prospective cohort that included all consecutive undergoing invasive mechanical ventilation due COVID-19...

10.1183/13993003.01426-2022 article EN cc-by-nc European Respiratory Journal 2022-11-17

The long-term clinical management and evolution of a cohort critical COVID-19 survivors have not been described in detail. We report prospective observational study patients admitted to the ICU between March August 2020. follow-up post-COVID consultation comprised symptoms, pulmonary function tests, 6-minute walking test (6MWT), chest computed tomography (CT). Additionally, questionnaires evaluate prevalence post-COVID-19 syndrome were administered at 1 year. A total 181 during period. They...

10.3389/fmed.2022.897990 article EN cc-by Frontiers in Medicine 2022-07-14
Flavia Galli Francesco Bindo Ana Motos Laia Fernández‐Barat Enric Barbeta and 95 more Albert Gabarrús Adrián Ceccato Jesús F. Bermejo‐Martin Ricard Ferrer Jordi Riera Óscar Peñuelas José Ángel Lorente David de Gonzalo-Calvo Rosario Menéndez Jessica González Sofia Misuraca Andrea Palomeque Rosario Amaya-Villar José M. Añón Ana Balan Mariño Carme Barberà José Barberán Aaron Blandino Ortíz Elena Bustamante‐Munguira Jesús Caballero María Luisa Cantón‐Bulnes Cristina Carbajales Pérez Nieves Carbonell Mercedes Catalán-González Raúl de Frutos Nieves Franco Cristobal Galbán‐Malagón Ana López Lago Víctor D. Gumucio-Sanguino María del Carmen de la Torre Emilio Díaz Ángel Estella Elena Curto J.L. García Garmendia José Manuel Gómez Arturo Huerta Ruth Noemí Jorge García Ana Loza-Vázquez Judith Marín‐Corral M.C. Martín Delgado Amalia Martínez de la Gándara Ignacio Martínez Varela Juan López Messa Guillermo M. Albaiceta María Teresa García Nieto Mariana Andrea Novo Yhivian Peñasco Felipe Pérez‐García Juan Carlos Pozo Laderas Pilar Ricart Víctor Sagredo-Meneses Ángel Sánchez-Miralles Susana Sancho Chinesta Ferran Roche‐Campo Lorenzo Socías Jordi Solé‐Violán Fernando Suarez‐Sipmann Luis Tamayo Lomas Josep Trenado Alejandro Úbeda Luis Jorge Valdivia Pablo Vidal María Victoria Boado Alejandro Rodríguez Massimo Antonelli Francesco Blasi Ferrán Barbé Antoní Torres Rafael Máñez Felipe Rodrı́guez de Castro María Mora Aznar Mateu Torres María Martínez-Martínez Cynthia Alegre Sofía Contreras Javier Trujillano Montse Vallverdú Miguel Leonardo García León Mariona Badía Begoña Balsera Luis Serviá Judit Vilanova Silvia Rodríguez Neus Montserrat Sílvia Iglesias Javier Prados Sula Carvalho Mar Miralbés Josman Monclou Gabriel Jiménez Jordi Codina Estela Val Pablo Pagliarani Jorge Rubio Dulce Morales

Although the prevalence of community-acquired respiratory bacterial coinfection upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been reported to be < 5%, almost three-quarters received antibiotics. We aim investigate whether procalcitonin (PCT) or C-reactive protein (CRP) could helpful biomarkers identify among COVID-19 pneumonia. carried out a multicentre, observational cohort study including consecutive admitted 55 Spanish intensive care units (ICUs). The...

10.1007/s00134-023-07161-1 article EN cc-by-nc Intensive Care Medicine 2023-07-28

Elucidating the pathobiological mechanisms underlying post-acute pulmonary sequelae following SARS-CoV-2 infection is essential for early interventions and patient stratification. Here, we investigated potential of microRNAs (miRNAs) as theranostic agents pulmoprotection in critical illness survivors. Multicenter study including 172 ICU Diffusion impairment was defined a lung-diffusing capacity carbon monoxide (D

10.1016/j.omtn.2024.102118 article EN cc-by Molecular Therapy — Nucleic Acids 2024-01-10

Circulating cell-free microRNAs (miRNAs) are promising biomarkers for medical decision-making. Suitable endogenous controls essential to ensure reproducibility. We aimed identify and validate reference miRNAs qPCR data normalization in samples from SARS-CoV-2-infected hospitalized patients. used plasma (n = 170) COVID-19 patients collected at hospital admission (COVID-Ponent project, www.clinicaltrials.gov/NCT04824677). First, 179 were profiled using RT–qPCR. After stability assessment,...

10.1016/j.ijbiomac.2024.131926 article EN cc-by International Journal of Biological Macromolecules 2024-04-28

The pathophysiology of COVID-19-related critical illness is not completely understood. Here, we analyzed the microRNA (miRNA) profile bronchial aspirate (BAS) samples from COVID-19 and non-COVID-19 patients admitted to ICU identify prognostic biomarkers fatal outcomes define molecular pathways involved in disease adverse events.Two patient populations were included (n = 89): (i) a study population composed critically ill patients; (ii) prospective cohort survivors non-survivors among...

10.3389/fmed.2021.756517 article EN cc-by Frontiers in Medicine 2022-02-03

There is a limited understanding of the pathophysiology postacute pulmonary sequelae in severe COVID-19. The aim current study was to define circulating microRNA (miRNA) profiles associated with function and radiologic features survivors SARS-CoV-2-induced ARDS. included patients who developed ARDS secondary SARS-CoV-2 infection (n = 167) group infected did not develop 33). Patients were evaluated 3 months after hospital discharge. follow-up complete evaluation chest computed tomography....

10.1080/22221751.2022.2081615 article EN cc-by Emerging Microbes & Infections 2022-05-23

Abstract Background and Purpose The post‐acute sequelae of SARS‐CoV‐2 infection pose a significant global challenge, with nearly 50% critical COVID‐19 survivors manifesting persistent lung abnormalities. lack understanding about the molecular mechanisms effective treatments hampers their management. Here, we employed microRNA (miRNA) profiling to decipher systemic underpinnings pulmonary complications. Experimental Approach We conducted longitudinal investigation including 119 survivors. A...

10.1111/bph.16330 article EN cc-by-nc-nd British Journal of Pharmacology 2024-02-15

To determine the association between Obstructive Sleep Apnea (OSA) with long-term symptoms and inflammatory cytokines, exploring changes 4-months 1-year after COVID-19 infection. We conducted an observational, prospective cohort study, including patients ≥18 years old confirmed diagnosis of April to July 2020. All participants underwent two clinical follow-up visits, first at (Visit 1) second 1 year, SARS-CoV-2 infection 2). Plasma glucose, total cholesterol, HDL, triglycerides. Regarding...

10.3389/fmed.2022.884218 article EN cc-by Frontiers in Medicine 2022-06-14

The identification of critically ill COVID-19 patients at risk fatal outcomes remains a challenge. Here, we first validated candidate microRNAs (miRNAs) as biomarkers for clinical decision-making in patients. Second, constructed blood miRNA classifier the early prediction adverse ICU.This was multicenter, observational and retrospective/prospective study including 503 admitted to ICU from 19 hospitals. qPCR assays were performed plasma samples collected within 48 h upon admission. A 16-miRNA...

10.1186/s12931-023-02462-x article EN cc-by Respiratory Research 2023-06-17

Sirtuin 1 (Sirt1) is a NAD+ dependent lysine deacetylase associated with the pathogenesis of various diseases including cancer. In many cancer types Sirt1 expression increased. Higher levels have been metastasis and poor prognosis. However, tumor suppressing properties also observed in some instances even dual role for same type has reported. Increased activity linked to life span extension cells respectively organisms by promoting DNA repair processes downregulation suppressor proteins....

10.3389/fonc.2020.00657 article EN cc-by Frontiers in Oncology 2020-04-30
Coming Soon ...